Drug Treatment of Oral Submucous Fibrosis: A Review of the Literature

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 7, 2009, Pages 1510-1515

  Jiang, Xiaowen ^a   Hu, Jing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETAMETHASONE; BUFLOMEDIL; BUPHENINE; CARDIOVASCULAR AGENT; CHYMOTRYPSIN; COLLAGEN; COLLAGENASE; DEXAMETHASONE; ELEMENT; ENZYME; GAMMA INTERFERON; GLUCOCORTICOID; HERBACEOUS AGENT; HYALURONIDASE; HYDROCORTISONE; LYCOPENE; MAGNESIUM; PENTOXIFYLLINE; RESOLVASE; RETINOL; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETATE; VITAMIN; VITAMIN B COMPLEX; ZINC;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD RHEOLOGY; BLOOD VISCOSITY; CANCER PREVENTION; CELL DIVISION; CELL STRESS; CELLULAR IMMUNITY; CEREBRAL ARTERY DISEASE; CIRCULATION; CLINICAL TRIAL; COLLAGEN SYNTHESIS; DNA SYNTHESIS; DRUG EFFICACY; DRUG MECHANISM; DRUG OVERDOSE; FIBRINOLYTIC THERAPY; FIBROBLAST; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HEART PROTECTION; HUMAN; INFORMATION RETRIEVAL; INTERMITTENT CLAUDICATION; LEUKOPENIA; LYMPHOCYTE; MEDICAL LITERATURE; MICROCIRCULATION; MOUTH DISEASE; MOUTH ULCER; MULTIINFARCT DEMENTIA; NATURAL KILLER CELL; NEOPLASM; NEUROTOXICITY; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; SICKLE CELL ANEMIA; STEROID THERAPY; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION; TEA; TISSUE REPAIR; TREATMENT DURATION; TREATMENT OUTCOME; TRISMUS; ULCER HEALING; WOUND HEALING;

ANTIOXIDANTS; COLLAGENASES; GLUCOCORTICOIDS; HUMANS; HYALURONOGLUCOSAMINIDASE; ORAL SUBMUCOUS FIBROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRACE ELEMENTS; VASODILATOR AGENTS; VITAMINS;

EID: 66949168043     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.12.056     Document Type: Article

References (48)

1. Schwartz J. Atrophia idiopathic (tropica) mucosa oris. Demenstrated at the 11th Int Dent Congress. London (1952)
2. Joshi S.G. Submucous fibrosis of palate and pillars. Indian J Otolaryngol 4 (1953) 1
3. Rajendran R. Oral submucous fibrosis: Etiology, pathogenesis, and future research. Bull WHO 72 (1994) 985
4. Tilakaratne W.M., Klinikowski M.F., Saku T., et al. Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol 42 (2006) 561
5. Trivedgy C.R., Craig G., and Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol 7 (2002) 115
6. Pindborg J.J., Chawla T.N., Srivastava A.N., et al. Epithelial changes in oral submucous fibrosis. Acta Odontol Scand 23 (1965) 277
7. Scutt A., Meghji S., Canniff J.P., et al. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia 43 (1987) 391
8. Shieh T.Y., and Yang J.F. Collagenase activity in oral submucous fibrosis. Proc Nat Sci Repub China 16 (1992) 106
9. Kuo M.Y.P., Chen H.M., Hahn L.J., et al. Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74 (1995) 1783
10. Ma R.H., Tsai C.C., and Shieh T.Y. Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med 24 (1995) 407
11. Tsai C.C., Ma R.H., and Shieh T.Y. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 28 (1999) 59
12. Haque M.F., Meghji S., Khitab U., et al. Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29 (2000) 123
13. Tsai C.C., Ma R.H., and Shieh T.Y. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med 28 (1999) 59
14. Canniff J.P., Harvey W., and Harris M. Oral submucous fibrosis: Its pathogenesis and management. Br Dent J 160 (1986) 429
15. Gupta D., and Sharma S.C. Oral submucous fibrosis-A new treatment regimen. J Oral Maxillofac Surg 46 (1988) 830
16. Golhar S.V., Mahore M.N., and Narkhede S. Oral submucous fibrosis. Dent Dialogue 12 (1987) 44
17. Kakar P.K., Puri R.K., and Venkatachalam V.P. Oral submucous fibrosis-Treatment with hyalase. J Laryngol Otol 99 (1985) 57
18. Kumar A., Sharma S.C., Sharma P., et al. Beneficial effect of oral zinc in the treatment of oral submucous fibrosis. Indian J Pharmacol 23 (1991) 236
19. Khanna J.N., and Andrade N.N. Oral submucous fibrosis: A new concept in surgical management. Int J Oral Maxillofac Surg 24 (1995) 433
20. Lai D.R., Chen H.R., Lin L.M., et al. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 24 (1995) 402
21. Kumar A., Bagewadi A., Keluskar V., et al. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 207
22. Pindborg J.J. Oral epithelial changes in thirty Indians with oral cancer and submucous fibrosis. Cancer 20 (1967) 1141
23. Hamner J.E., Looney P.D., and Cbaused J.M. Submucous fibrosis. Oral Surg 37 (1974) 412
24. Sirsat S.M., and Pindborg J.J. Subepithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 70 (1967) 161
25. Reichart P.A., van Wyk C.W., Becker J., et al. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF). J Oral Pathol Med 23 (1994) 394
26. Rajalalitha P., and Vali S. Molecular pathogenesis of oral submucous fibrosis-A collagen metabolic disorder. J Oral Pathol Med 34 (2005) 321
27. Shieh D.H., Chiang L.C., and Shieh T.Y. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 39 (2003) 728
28. Yang S.F., Hsieh Y.S., Tsai C.H., et al. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39 (2003) 367
29. Lin H.J., and Lin J.C. Treatment of oral submucous fibrosis by collagenase: Effects on oral opening and eating function. Oral Dis 13 (2007) 407
30. Rajendran R. Oral submucous fibrosis: Etiology, pathogenesis, and future research. Bull WHO 72 (1994) 985
31. Phatak A.G. Hypercoagulation and fibrinolysis in oral submucous fibrosis. Am J Clin Pathol 81 (1984) 623
32. Rajendran R., Rani V., and Shaikh S. Pentoxifylline therapy: A new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 17 (2006) 190
33. Samlaska C.P., and Winfield E.A. Pentoxifylline-Clinical review. J Am Acad Dermatol 30 (1994) 603
34. Sharma J.K., Gupta A.K., Mukhija R.D., et al. Clinical experience with the use of peripheral vasodilator in oral disorders. Int J Oral Maxillofac Surg 16 (1987) 695
35. Li X.M., and Tang J.Q. Clinical treatment observation of tea pigment for oral submucous fibrosis. Hua Xi Kou Qiang Yi Xue Za Zhi 16 (1998) 50
36. Chiu C.J., Chang M.L., Chiang C.P., et al. Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 11 (2002) 646
37. Singh M., Krishanappa R., Bagewadi A., et al. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 40 (2004) 591
38. Gupta S., Reddy M.V.R., and Harinath B.C. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian J Clin Biochem 19 (2004) 138
39. Heber D., and Lu Q.Y. Overview of mechanisms of action of lycopene. Exp Biol Med 227 (2002) 920
40. Gupta P.C., Hebert J.R., Bhonsle R.B., et al. Dietary factors in oral leukoplakia and submucous fibrosis in a population-based case control study in Gujarat, India. Oral Dis 4 (1998) 200
41. Anuradha C.D., and Devi C.S. Serum protein, ascorbic acid and iron and tissue collagen in oral submucous fibrosis-A preliminary study. Indian J Med Res 98 (1993) 147
42. Maher R., Aga P., Johnson N.W., et al. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 27 (1997) 41
43. Borle R.M., and Borle S.R. Management of oral submucous fibrosis: A conservative approach. J Oral Maxillofac Surg 49 (1991) 788
44. Trivedy C., Baldwin D., Warnakulasuriya S., et al. Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet 349 (1997) 1447
45. Haque M.F., Meghji S., Nazir R., et al. Interferon gamma (IFN-γ) may reverse oral submucous fibrosis. J Oral Pathol Med 30 (2001) 12
46. Lee Y.C., Park M.H., and Baek N.H. Effect of gamma-interferon on fibroblasts proliferation and collagen synthesis after glaucoma filtering surgery in white rabbits. Korean J Ophthalmol 5 (1991) 59
47. Nguyen K.D., Hoang A.T., and Lee D.A. Transcriptional control of human Tenon's capsule fibroblasts collagen-synthesis in vitro by gamma interferon. Invest Ophthalmol Vis Sci 35 (1994) 3064
48. Tai Y.S., Liu B.Y., Wang J.T., et al. Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. J Oral Pathol Med 30 (2001) 618